| Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673) |
|---|
| 03/06/2008 | WO2008027526A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2008025163A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/06/2008 | WO2007149476A3 Assays for non-apoptotic cell death and uses thereof |
| 03/06/2008 | WO2007089688A3 Na/k-atpase ligand |
| 03/06/2008 | US20080060089 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom |
| 03/06/2008 | CA2662026A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity |
| 03/06/2008 | CA2660732A1 Methods relating to peripheral administration of nogo receptor polypeptides |
| 03/05/2008 | EP1030862B1 Viral clearance process |
| 03/05/2008 | CN100372870C Polyethylene glycol derivatives of thymosin alphal |
| 03/04/2008 | US7339044 Nematode PAN and ZP receptor-like sequences |
| 03/04/2008 | US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections |
| 03/04/2008 | US7338768 Carrier-reporter bead assemblies |
| 02/28/2008 | WO2008024300A1 SEMAPHORIN 7A PLAYS A CRITICAL ROLE IN TGF-β1-INDUCED PULMONARY FIBROSIS AND ALVEOLAR DESTRUCTION |
| 02/28/2008 | US20080051555 Support Having Affinity for Antibody |
| 02/28/2008 | US20080051299 DNA-protein fusions and uses thereof |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891104A2 Solid phase bound thymosin alpha1 and its synthesis |
| 02/26/2008 | US7335751 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/26/2008 | US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage |
| 02/26/2008 | US7335745 Vectors with DNA encoding pro polypeptides |
| 02/26/2008 | US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders |
| 02/26/2008 | US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/26/2008 | US7335729 PRO4320 polypeptide |
| 02/26/2008 | US7335636 SPRR1A and axonal regeneration |
| 02/26/2008 | US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 02/26/2008 | US7335362 Methods of treating pre-eclampsia or eclampsia |
| 02/21/2008 | US20080045736 Water-Soluble, Surface-Functionalized Nanoparticle for Bioconjugation Via Universal Silane Coupling |
| 02/21/2008 | US20080045694 Preparation of Solid Phase Bound Peptides or Pnas |
| 02/21/2008 | US20080044820 La1 - the genome of a lactobacillus strain |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1039873B1 Keratin-based hydrogel for biomedical applications and method of production |
| 02/19/2008 | USRE40089 Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor |
| 02/19/2008 | US7332587 Separation of target molecule from sample; obtain sample, incubate with oli bodies, isolate oil body bound target |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332583 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 02/19/2008 | US7332567 Fret protease assays for clostridial toxins |
| 02/19/2008 | US7332288 Highly sensitive assay which combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis to detect, enumerate and characterize carcinoma cells in the blood. |
| 02/19/2008 | US7331920 Glycopeptide antibiotics, combinational libraries of glycopeptide antibiotics and methods of producing same |
| 02/19/2008 | CA2263795C Chemically modified polypeptides |
| 02/14/2008 | WO2008019214A1 Modified erythropoietin |
| 02/14/2008 | WO2008017483A2 Spore surface displays of bioactive molecules |
| 02/14/2008 | US20080038838 Dioxin-Binding Material and Method of Detecting or Quantifying Dioxin |
| 02/14/2008 | CA2659990A1 Polyethylene glycol erythropoietin conjugates |
| 02/13/2008 | EP1885755A2 Anti-cd19 antibody therapy for autoimmune disease |
| 02/13/2008 | EP1832875A4 Biological microchip for multiple parallel immunoassay of compounds and immunoassay methods using said microchip |
| 02/13/2008 | CN101124315A Method for removal of viruses from blood by lectin affinity hemodialysis |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329505 Specific detection of proteolytic enzymes |
| 02/12/2008 | US7329499 Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes |
| 02/12/2008 | US7329496 Sequencing of surface immobilized polymers utilizing microflourescence detection |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/12/2008 | CA2090485C Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material |
| 02/07/2008 | WO2008016335A1 A microarray system and a process for producing microarrays |
| 02/07/2008 | US20080033148 Anti-il-tif antibodies and methods of using in inflammation |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | DE102006035899A1 New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample |
| 02/06/2008 | EP1883424A2 Methods for treating fibrotic conditions |
| 02/05/2008 | US7326773 PRO6493 antibodies |
| 02/05/2008 | US7326770 H. pylori fucosyltransferases |
| 02/05/2008 | US7326413 Antibodies against the PRO1434 polypeptide |
| 01/31/2008 | WO2008012528A1 N-terminal polysialylation |
| 01/30/2008 | EP1882700A1 Biotinylated MHC complexes and their uses |
| 01/29/2008 | US7323550 Anti-PRO4318 antibodies |
| 01/29/2008 | US7323545 PRO1885 polypeptides |
| 01/29/2008 | US7323544 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
| 01/29/2008 | US7323179 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 01/24/2008 | WO2005000095A3 Isoforms of brain natriuretic peptide |
| 01/24/2008 | US20080020942 Reagents and Methods for Appending Functional Groups to Proteins |
| 01/23/2008 | EP1879616A2 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 01/22/2008 | US7321022 Electrostatic layer-by-layer self assembly; exposing film to an oxidizing or reducing agent; alternating layers of oppositely charged polypeptides; 1st layer polypeptide contains sulfhydryl-containing amino acid; 2nd layer polypeptide has two amino acid sequences joined by a glycine a proline linker. |
| 01/22/2008 | US7320875 Screening for neutralizing hepatitis C virus antibodies in a blood sample utilizing an HCV E2 protein and a protein from a human or chimpanzee cell that has a molecular weight of 24 kd that binds to the E2 protein of HCV; comparing the amount of bound proteins to that in the absence of HCV antibodies |
| 01/22/2008 | US7320868 Leptin binding domain compositions and methods thereto |
| 01/17/2008 | WO2008006189A1 Mimotope receptors and inhibitors for platelet- platelet and platelet-endothelium interactions |
| 01/17/2008 | WO2006105490A3 Compositions and methods for treating diseases associated with phlpp |
| 01/17/2008 | CA2657310A1 Mimotope receptors and inhibitors for platelet-platelet and platelet-endothelium interactions |
| 01/16/2008 | EP1877420A1 Combination therapy in the treatment of cancer |
| 01/16/2008 | CN101104078A Polypeptide and protein medicine polyethylene coupling compound |
| 01/16/2008 | CN101104077A Recombinant human interleukin-2 and polyethylene coupling compound |
| 01/16/2008 | CN100362019C Recombinant erythropoietin with intracorporeal physical activity and modified by macrogol |
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319012 Generating library of preferential polypeptides; obtain nucleotide sequences, incubate with primers, amplify, recover amplification product, transform and express sequence incell, monitor and evaluate cell activity |
| 01/15/2008 | US7319002 Using 2-3,O-sialic acid immobilized solid support to detect adenoviral infection; pathogen diagnostics |
| 01/15/2008 | US7318922 Anti-PRO5337 antibodies |
| 01/15/2008 | CA2093427C Molecular clones of hiv-1 and uses thereof |
| 01/10/2008 | US20080008690 AAV virions with decreased immunoreactivity and uses therefor |
| 01/09/2008 | EP1875244A2 Proliferation of muc1 expressing cells |
| 01/09/2008 | EP1874933A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874932A2 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 01/09/2008 | EP1874816A2 Modulation of antibody effector function by hinge domain engineering |
| 01/09/2008 | EP1874342A2 Compositions and methods for cancer immunotherapy |
| 01/09/2008 | CN101103042A IRTA-2 antibodies and their uses |
| 01/08/2008 | US7317092 Nucleotide sequences coding polypeptide for use in the treatment of skin, kidney, cancer, nervous system, liver and cardiovascular disorders |
| 01/08/2008 | US7317088 PRO5993 polypeptides |
| 01/08/2008 | US7317083 PRO4501 polypeptides |
| 01/08/2008 | US7317081 PRO4371 polypeptides |